Early treatment phases typically start patients at lower unit amounts (2.4 units or 0.2 mg) and increase gradually every 4 weeks to allow the body to adjust and minimize nausea
However, this should only be done under the guidance of a healthcare professional, and patients should never attempt to combine the two on their own
A melanocortin receptor agonist belongs in receptor-pathway research context
Add a fiber supplement if bowel movements are less than daily
Yu J, Berga SL, Zou W, Taylor RN (2019) Interleukin-1 inhibits estrogen receptor-, progesterone receptors A and B and biomarkers of human endometrial stromal cell differentiation: implications for endometriosis
During the pivotal SURPASS clinical trial programme, which evaluated tirzepatide across diverse patient populations with type 2 diabetes, retinopathy-related adverse events were reported in a small proportion of participants